2-Aroylindoles and 2-Aroylbenzofurans with N-Hydroxyacrylamide Substructures as a Novel Series of Rationally Designed Histone Deacetylase Inhibitors-Reference-Cited by-同舟云学术

2-Aroylindoles and 2-Aroylbenzofurans with N-Hydroxyacrylamide Substructures as a Novel Series of Rationally Designed Histone Deacetylase Inhibitors

Published:2007-08-11 Issue:18 Volume:50 Page:4405-4418
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Mahboobi Siavosh¹,Sellmer Andreas¹,Höcher Heymo¹,Garhammer Christian¹,Pongratz Herwig¹,Maier Thomas¹,Ciossek Thomas¹,Beckers Thomas¹

Affiliation:

1. Department of Pharmaceutical Chemistry I, University of Regensburg, D-93040 Regensburg, Germany, and Therapeutic Area Oncology, ALTANA Pharma, a Member of the NYCOMED Group, D-78467 Konstanz, Germany

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0703136

Reference40 articles.

1. The language of covalent histone modifications

2. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of class I HDAC modulators: Inhibitors and degraders;European Journal of Medicinal Chemistry;2024-10

2. 1,3,5-Triazine Based Hydroxamic Acid Analogues as HDAC Inhibitors: Integrated Modelling by 3D QSAR, Hypogen Pharmacophore Based Virtual Screening and Molecular Dynamic Simulation Studies;2023-05-09

3. Wittig and Wittig–Horner Reactions under Sonication Conditions;Molecules;2023-02-18

4. Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent;Current Cancer Drug Targets;2023-01

5. 4th generation nonsteroidal aromatase inhibitors: An iterative SAR-guided design, synthesis, and biological evaluation towards picomolar dual binding inhibitors;European Journal of Medicinal Chemistry;2022-10